Author/Authors :
Madjd Zahra نويسنده Department of Pathology, Tehran University of Medical Sciences, Tehran, Iran , Akbari Abolfazl نويسنده Department of Physiology, Faculty of Veterinary, Shiraz University of Medical Sciences, Shiraz, Iran Akbari Abolfazl , Alinaghi Samaneh نويسنده Department of Cellular and Molecular Biology, Tonekabon
Branch, Islamic Azad University, Tonekabon, IR Iran , Mirzaei Alireza نويسنده Bone and Joint Reconstruction Research Center, Shafa
Orthopedic Hospital, Iran University of Medical Sciences, Tehran, IR
Iran , Amini Kadijani Azade نويسنده Basic and Molecular Epidemiology of Gastrointestinal
Disorders Research Center, Research institute for Gastroenterology
and Liver Diseases, Shahid Beheshti University of Medical Sciences,
Tehran, Iran , Tavoosidana Gholamreza نويسنده Department of Molecular Medicine, School of Advanced
Technologies in Medicine, Tehran University of Medical Sciences,
Tehran, Iran
Abstract :
Context To date, CSCs have been identified in a variety of
hematopoietic and solid tumors. Applying CSC in clinical implication
still depends on future studies to remove complexities including CSC
heterogeneity and CSC similarity to normal stem cells. However, several
potential clinical applications including therapeutic, diagnostic and
prognostic implications have been introduced for cancer stem cells
(CSC). In this review, we discuss previously considered and unconsidered
potential clinical application of CSCs including how CSCs could be
applied for pan-specific cancer screening and therapy. Evidence
Acquisition We will first discuss the previously proposed CSC clinical
implications using a brief review of the literature. Subsequently, we
will discuss some theoretical potential CSC implications which have not
been discussed before including pan-specific cancer screening and
therapy, and present confirmatory references for each part of our
hypothesis. Results We hypothetically demonstrated the presence of
similar markers in the CSC subset of different tumors and introduced it
as a way to simultaneously screen several cancers using one CSC marker.
Conclusions Simultaneous screening of several cancers applying one CSC
marker could be regarded as a novel high-value cost-conscious cancer
screening approach which might evolve cancer screening concept. However,
this application remains to be explored in the future instigations.